New York, April 13 -- Russia's Covid vaccine Sputnik V has been recommended for use in India by a committee of experts as the country battles a record spike in virus cases in the country. If approved by regulator DCGI, this will be the third vaccine to be used in India after Serum Institute of India'sCovishield- developed by Oxford-AstraZeneca - and Bharat Biotech'sCovaxin.

Sputnik V,manufactured in India by Dr Reddy's, has the highest effectiveness - 91.6 per cent - after the Moderna and Pfizer shots. Dr Reddy's had applied on February 19 for emergency use of the vaccine, which is in Phase 3 of clinical trials in India.

After the Subject Expert Committee (SEC)'s recommendation, the vaccine has to be greenlit by the Drug Controller Gene...